ROS and miRNA Dysregulation in Ovarian Cancer Development, Angiogenesis and Therapeutic Resistance.
ROS and miRNA Dysregulation in Ovarian Cancer Development, Angiogenesis and Therapeutic Resistance.
复制标题
ROS和miRNA在卵巢癌发展、血管生成和治疗抗性中的失调。
DOI：
10.3390/ijms23126702
复制
发表时间：
2022-06-16
影响因子：
5.6
通讯作者：
Jiang, Bing-Hua
中科院分区：
文献类型：
--
作者：
Stieg, David C.;Wang, Yifang;Liu, Ling-Zhi;Jiang, Bing-Hua
The diverse repertoires of cellular mechanisms that progress certain cancer types are being uncovered by recent research and leading to more effective treatment options. Ovarian cancer (OC) is among the most difficult cancers to treat. OC has limited treatment options, especially for patients diagnosed with late-stage OC. The dysregulation of miRNAs in OC plays a significant role in tumorigenesis through the alteration of a multitude of molecular processes. The development of OC can also be due to the utilization of endogenously derived reactive oxygen species (ROS) by activating signaling pathways such as PI3K/AKT and MAPK. Both miRNAs and ROS are involved in regulating OC angiogenesis through mediating multiple angiogenic factors such as hypoxia-induced factor (HIF-1) and vascular endothelial growth factor (VEGF). The NAPDH oxidase subunit NOX4 plays an important role in inducing endogenous ROS production in OC. This review will discuss several important miRNAs, NOX4, and ROS, which contribute to therapeutic resistance in OC, highlighting the effective therapeutic potential of OC through these mechanisms.
登录
查看更多内容
影响因子：
2.9
作者：
Zhou F;Chen J;Wang H
通讯作者：
Wang H
影响因子：
4.8
作者：
Block, Karen;Gorin, Yves;Abboud, Hanna E.
通讯作者：
Abboud, Hanna E.
影响因子：
37.3
作者：
Banskota, Suhrid;Regmi, Sushil C.;Kim, Jung-Ae
通讯作者：
Kim, Jung-Ae
影响因子：
56.9
作者：
BAEHNER, RL;NATHAN, DG
通讯作者：
NATHAN, DG
影响因子：
3.3
作者：
BERSE, B;BROWN, LF;SENGER, DR
通讯作者：
SENGER, DR